The Oregon Clinic | Pulmonary Critical Care & Sleep Medicine East

Research site

(Unclaimed)

Location

1111 NE 99th Avenue Suite 200, Portland, Oregon, United States of America

Site insights

Top conditions

Top treatments

Nintedanib

Droxidopa

Treprostinil

BI 1015550

Tiotropium

Sildenafil

Guselkumab

Macitentan

Lebrikizumab

Sitaxsentan

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 46 total trials

A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)

A prospective, multicenter, single-arm study to evaluate the safety and effectiveness of the eCoin® implanted tibial nerve stimulator in subjects wit...

Enrolling

Urinary Urge Incontinence

Incontinence, Urinary

Device: eCoin Tibial Nerve Stimulation

A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease (DUET-CD)

The purpose of this study is to evaluate the efficacy of JNJ-78934804 at Week 48 compared to guselkumab and golimumab.

Active, not recruiting

Crohn's Disease

Biological: JNJ-78934804

Biological: Golimumab

A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease (GRAVITI)

The purpose of this study is to evaluate the efficacy and safety of guselkumab in participants with Crohn's disease.

Active, not recruiting

Crohn Disease

Drug: Guselkumab Dose 3

Drug: Placebo

A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (ARNASA)

This study will evaluate the efficacy and safety of astegolimab compared with placebo in participants with chronic obstructive pulmonary disease (COP...

Enrolling

Chronic Obstructive Pulmonary Disease (COPD)

Drug: Astegolimab

Drug: Placebo

Locations recently updated

A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

This study is open to adults with a lung disease called Idiopathic Pulmonary Fibrosis (IPF). People can join the study if they are 40 years or older....

Active, not recruiting

Idiopathic Pulmonary Fibrosis

Drug: Placebo

Drug: BI 1015550

Locations recently updated

A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)

This study is open to adults with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs). People who have a form of PF-ILD other than Idiopathic...

Active, not recruiting

Lung Diseases, Interstitial

Drug: BI 1015550

Drug: Placebo

Extension Study of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-OLE)

Study RIN-PF-302 is designed to evaluate the long-term safety and tolerability of inhaled treprostinil in subjects with idiopathic pulmonary fibrosis.

Invitation-only

Idiopathic Pulmonary Fibrosis

Interstitial Lung Disease

Device: Treprostinil Ultrasonic Nebulizer

Drug: Inhaled Treprostinil

Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension (UNISUS)

The purpose of this study is to demonstrate superiority of macitentan 75 milligrams (mg) in prolonging the time to the first clinical events committe...

Enrolling

Pulmonary Arterial Hypertension

Drug: Placebo

Drug: Macitentan 75 mg